Search

everythinglearnresearchcommunity

for

Search:↓

Nutritional supplements may help improve hair growth in female pattern hair loss.

Abnormal Hedgehog signaling in blood cancers may help tumors grow and resist chemotherapy, suggesting potential for targeted treatments.

XMU-MP-1 stops cell growth in a human mini-organ and reduces the effectiveness of the chemotherapy drug paclitaxel.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

The supplement highlighted advancements and challenges in plastic and reconstructive surgery, including the impact of smoking, chemotherapy, and new treatments like Tafluprost for hair loss.

Scalp cooling can effectively prevent hair loss during chemotherapy, improving patients' quality of life.

Permanent hair loss after a stem cell transplant can be a sign of chronic immune system attack on the scalp.

Activating NRF2 might help treat hair disorders by improving antioxidant defenses.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

The protein ER71/ETV2 helps regrow hair after chemotherapy by improving the growth of new blood vessels.

The treatment combining docetaxel, cisplatin, and 5-FU is feasible and effective for advanced head and neck cancer.

Ozone therapy might improve cancer treatment and reduce its side effects.

Hair casts and cutaneous spicules can be signs of multiple myeloma.

Some breast cancer patients on hormonal therapy may develop male or female pattern hair loss, which can sometimes be improved with topical treatments.

A woman with high testosterone and an adrenal nodule had an ovarian tumor causing her symptoms, which improved after the tumor was removed.

Hair loss due to scalp metastasis from breast cancer, known as Neoplastic Alopecia, has a better survival rate than other scalp metastases and requires a biopsy for diagnosis.

Melatonin may protect hair follicle cells from damage caused by a chemotherapy drug.

Early baldness in men may indicate risks for obesity, metabolic syndrome, insulin resistance, and heart disease, similar to women with PCOS. Alopecia areata is often linked with autoimmune diseases and mental health issues. Certain hair disorders are due to genetic issues, and chemotherapy can cause hair loss through specific biological pathways. Iron deficiency's link to hair loss is still disputed.

VEGF helps squamous cell carcinoma grow in ways beyond just blood vessel formation.

Dermatologists should carefully manage hair loss in cancer patients to improve their quality of life.

Folliculotropic mycosis fungoides has a worse prognosis than other types, with survival rates varying significantly based on subtype and organ involvement.

A woman's severe hormone imbalance after menopause led to finding a rare ovarian tumor, treated by surgery.

Horticultural therapy helped cancer patients feel hopeful and positive about their disease experience.

Radiation therapy with chemotherapy can cause severe, long-lasting hair loss.

Up to 50% of women may experience significant hair loss by age 50, with various causes and treatments available.

Hair loss in children can be caused by fungal infections, trauma, autoimmune disorders, or stress, and treatments vary depending on the cause.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

Higher doses of cranial irradiation are linked to permanent hair loss.